Apneic effects of cholecystokinin in unanaesthetized fetal sheep.
The effects on breathing movements and sleep state of cholecystokinin octapeptide (CCK-8) and its antagonist, proglumide, have been studied in unanaesthetised fetal lambs of 124-142 days gestation. CCK-8 when given into a lateral cerebral ventricle as bolus injections of 10-500 ng caused dose-related periods of apnea ranging from 63-214 min. When given as a 100 ng bolus followed by a 50 ng/h infusion for 2 h there was a prolonged period of apnea lasting 331 +/- 56 min. There was no effect of CCK-8 when given in higher doses (1-50 micrograms). The antagonist proglumide reversed the apnea induced by CCK-8 infusion, but had no effect when given alone, nor did it affect the normal fetal depressive response to hypoxia. Neither CCK-8 nor proglumide had any effect on electrocortical activity. We conclude that CCK has no role in the inhibitory mechanisms causing the apnea associated with high voltage electrocortical activity or hypoxia in the fetus. Furthermore CCK does not appear to be involved in the regulation of sleep state in the fetal lamb.
Bennet
L
L
Department of Paediatrics, School of Medicine, University of Auckland, New Zealand.
Johnston
B M
BM
Gluckman
P D
PD
D000818:Animals; D001049:Apnea / Q000139:chemically induced*; D004305:Dose-Response Relationship, Drug; D007276:Injections, Intraventricular; D011377:Proglumide / Q000494:pharmacology; D015656:Respiratory Mechanics / Q000187:drug effects*; D012756:Sheep; D012844:Sincalide / Q000494:pharmacology*; D012894:Sleep Stages / Q000187:drug effects
D011377:Proglumide; D012844:Sincalide